Toward the development of a Mood Disorders Insight Scale: modification of Birchwood's Psychosis Insight Scale
Toward the development of a Mood Disorders Insight Scale: modification of Birchwood's Psychosis Insight Scale
复制标题
DOI：
10.1016/s0165-0327(02)00102-7
复制
发表时间：
2003-10-01
影响因子：
6.6
通讯作者：
Sproule, BA
中科院分区：
文献类型：
--
作者：
Sturman, ED;Sproule, BA
背景资料：洞察力被定义为：（1）对精神病学的认识，（2）将症状归因于精神健康障碍的能力，以及（3）遵守治疗。自知力与服药依从性、病程及转归有关。目前用于测量洞察力的工具仅限于那些主要在住院精神病患者中得到验证的工具。我们的目标是开发一个可靠和有效的自我报告量表，用于门诊或住院患者的情绪障碍。为此，我们对Birchwood等人[1994，Acta Psychiatr. Scand. 89，62]精神病的洞察力量表。方法：该量表是通过修改项目，从以前的自我报告量表。具体而言，住院治疗，精神病和目前的精神病学的假设被删除，并增加了与情绪状态相关的项目。该量表包括在一组由参与情绪稳定剂药物研究的门诊患者和住院患者完成的测量中。结果：受试者（n = 101，66.3%女性，中位年龄44岁）完成量表的时间约为2-3分钟。总体评分较高（平均值= 10.3/12）。使用测试-再测试确定可靠性（r=0.75 n=45）。有效性检验主要基于临床医生评分（r=0.49，n=69）。结论：新量表有望成为一种快速评估心境障碍患者自知力的方法。(C)2002 Elsevier B. V.保留所有权利。
Background: Insight has been defined as: (1) recognition of symptomatology, (2) the ability to attribute symptoms to a mental health disorder, and (3) complying with treatment. Insight is related to medication compliance, course of illness and outcome. Current instruments for measuring insight are limited to those that have been validated primarily in hospitalized patients with psychosis. Our objectives were to develop a reliable and valid self-report scale for use in outpatients or inpatients with mood disorders. Toward this end we made extensive revisions of the Birchwood et al. [1994, Acta Psychiatr. Scand. 89, 62] Insight Scale for Psychosis. Methods: The scale was developed by modifying items from a previous self-report scale. Specifically, assumptions of hospitalizations, psychosis, and current symptomatology were removed and items related to mood state were added. The scale was included in a battery of measures completed by Outpatients and inpatients participating in a study of mood stabilizer medications. Results: Subjects (n = 101, 66.3% female, median age 44 years) took approximately 2-3 min each to complete the scale. Overall scores were high (Mean = 10.3 out of 12). Reliability was determined using test-retests (r=0.75 n=45). Validity testing was based mainly on clinician ratings (r=0.49, n=69). Conclusion: The new scale shows promise as a quick method for assessing insight in patients with mood disorders. (C) 2002 Elsevier B.V. All rights reserved.